Logo
Aessoa Deep with Lidocaine Monophasic Dermal Filler (1 x 1 ml)

Aessoa Deep with Lidocaine Monophasic Dermal Filler (1 x 1 ml)

Aessoa

Hyaluronic acid dermal filler (medical device)
  • European CE Certified hyaluronic acid dermal filler (Aessoa range documented by distributors as CE marked medical devices)
  • Described by distributors and wholesalers as compliant with European medical device regulations (EU MDR) for injectable HA dermal fillers
  • Brand Level information indicates that all products in the Aessoa filler range are European CE certified under Oreon Life Science
Monophasic cross-linked hyaluronic acid injectable gel with lidocaine for moderate to deep wrinkles and lip augmentation

Description

Aessoa Deep with Lidocaine is a CE-certified monophasic, cross-linked hyaluronic acid dermal filler containing lidocaine, developed and manufactured by S.THEPHARM and launched by Oreon Life Science under the Aessoa brand. It is designed for the correction of moderate to deep facial wrinkles and folds such as nasolabial folds, glabellar lines, and marionette lines, and is widely used for lip augmentation and contouring as well as non-surgical correction of the nose. The product is supplied as a 1.0 ml prefilled syringe containing non-animal-derived hyaluronic acid at 24 mg/ml and lidocaine at 3 mg/ml. It is injected into the mid-dermis to mid-deep/subcutaneous layers by trained medical or aesthetic professionals and provides long-lasting volumising and wrinkle-smoothing effects, with reported duration of up to approximately 15–18 months depending on patient and treatment factors.

Bnefits

  • Correction of moderate to deep facial wrinkles and folds, including nasolabial folds, glabellar lines, and marionette lines
  • Lip augmentation and shaping, providing natural-looking volume and contour to shapeless or poorly defined lips
  • Non-surgical improvement of nasal contours (rhinoplasty-type contour refinement) in suitable patients
  • Monophasic, cross-linked hyaluronic acid gel (24 mg/ml) for durable volume restoration and structural support
  • Includes lidocaine 3 mg/ml to improve patient comfort during injection
  • Non-animal-derived hyaluronic acid, designed for good biocompatibility
  • Long-lasting clinical effect typically reported up to around 15–18 months, subject to individual factors such as metabolism and treatment area
  • Supplied as a ready-to-use, prefilled 1.0 ml syringe for professional use

Indications

  • Correction of moderate to deep wrinkles and folds of the face, including nasolabial folds
  • Treatment of glabellar folds (frown lines) and marionette lines
  • Lip augmentation and contouring (used as a lip filler to enhance lip volume and shape)
  • Non-surgical contouring and correction of the nose (rhinoplasty-style enhancement) in aesthetic practice
  • General restoration of lost volume and improvement of facial contours in mid-dermal to subcutaneous planes, as determined by a trained professional

Composition

  • Non-animal-derived, cross-linked hyaluronic acid 24 mg/ml
  • Lidocaine (local anaesthetic) 3 mg/ml
  • Other excipients used to formulate the sterile, transparent, viscoelastic HA gel: Not publicly listed

Formulation

  • Monophasic, cross-linked hyaluronic acid gel with lidocaine
  • Sterile, transparent, viscoelastic injectable implant for intradermal/subdermal use
  • Intended injection depth: mid-dermis to mid-deep/subcutaneous layers depending on indication (wrinkles vs volume/lip or nose correction)
  • Non-animal origin hyaluronic acid
  • Supplied as a single-use prefilled syringe containing 1.0 ml of gel; no needles supplied in the pack (27G needle commonly recommended by distributors)

Packaging

  • Pack consists of 1 x 1.0 ml prefilled glass syringe of Aessoa Deep with Lidocaine
  • Single-use sterile syringe presentation for injection by trained professionals
  • No needles included in the pack; distributors recommend use of a 27G needle
  • External carton and internal blister/sterile packaging details (materials, artwork) are not fully specified in publicly available distributor information

Usage

  • Product is intended for injection only by trained healthcare or aesthetic professionals familiar with facial anatomy and hyaluronic acid filler techniques; it is not for self-administration by patients.
  • Inject into the mid-dermis to mid-deep or subcutaneous layers depending on the indication (e.g., mid-dermis for wrinkles and folds; appropriate depth for lip augmentation or nasal contouring) following the official instructions for use (IFU).
  • Use aseptic technique and standard dermal filler injection practices, selecting needle gauge and injection technique (linear threading, fanning, etc.) according to professional judgement.
  • Aessoa Deep with Lidocaine should be used in accordance with the manufacturer’s instructions and any local clinical guidelines; practitioners should read the full instructions for use before treatment.
  • The syringe is single-use only; any unused product after opening should be discarded in accordance with local regulations for sharps and medical waste.
  • Patients should be informed of potential risks and standard post-procedure care, and they should follow the aftercare advice given by the treating professional.

Contraindications

  • Not publicly listed

Adverse Effects

  • Not publicly listed

Storage Conditions

  • Not publicly listed

Duration

Public distributor information states that the effects of Aessoa Deep with Lidocaine can last up to approximately 15\u201318 months, depending on patient factors (such as lifestyle and metabolism) and the specific treated area; actual duration varies between individuals and must be assessed clinically.

Onset

Not publicly listed

Browse more Hyaluronic acid dermal filler (medical device)

Top Treatments

Top Cities in the UK